Skip to content

Comparison of Two Type of Laryngeal Mask : I-Gel & LMA ProSeal

LMA ProSeal & I-Gel : a Prospective Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00624403
Acronym
I-Gel
Enrollment
700
Registered
2008-02-27
Start date
2008-03-01
Completion date
2013-12-01
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endotracheal Intubation

Keywords

Anesthesia, Laryngeal mask airway

Brief summary

The i-gel is a new supra glottic airway device with a non inflatable cuff and an oesophageal vent. The aim of this study is to compare this device to the LMA ProSeal. The study is approved by the institutional ethic committee. 222 patients will be enrolled in each group. The objectives of the study will be to compare insertion success rate, leak pressure, ventilatory parameters and adverse event rate.

Detailed description

Supraglottic airway devices are now widely used for surgery requiring general anesthesia. Airway devices are safe and their morbidity rate is very low. The i-gel (Intersurgical Ltd, Wokingham, Berkshire, UK) is a new single-use non-inflatable supraglottic airway device that has not been evaluated in a comparative study. The aim of this study is to compare i-gel with the LMA ProSeal in a randomized study. Anesthesia protocol is standardized. The supraglottic devices are compared in term of insertion success rate, leak pressure, ventilatory parameters and adverse events. The aim is to demonstrate an enhancement in term of insertion success rate and a diminution of the adverse events. Statistical analysis will used percentage, confidence interval and chi 2 or Fischer's exact test for qualitative data. Quantitative data will be analyzed in mean, standard deviation. Comparison will be made with a student t test or a wilcoxon test. P \< 0,05 is statistically significant.

Interventions

DEVICELaryngeal mask insertion (LMA ProSeal)

Laryngeal mask insertion

DEVICELaryngeal mask insertion (I-Gel)

Laryngeal mask insertion

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Weight \> 30 kg * Surgery allowing the use of laryngeal mask as airway management * Written informed consent

Exclusion criteria

* Difficult intubation criteria (defined by French Anesthesia-Reanimation Society) * Pulmonary disease * Gastroesophageal reflux antecedent * Coeliosurgery * Inhalation risk * Hiatus hernia

Design outcomes

Primary

MeasureTime frame
Insertion success rateAt firste attempt of insertion

Secondary

MeasureTime frame
Perioperative morbidityPerioperative period
Airway sealing pressureOnce, when efficient ventilation is reached
Accessibility for stomach tube insertionJuste after laryngeal mask insertion
Fibre-optic gradeAfter insertion

Countries

France

Contacts

PRINCIPAL_INVESTIGATORAnne-Marie CROS, Dr

University Hospital, Bordeaux

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026